HopeStage
Back to all studies
WithdrawnNCT05991622

Combined Injectable Treatment for HIV and OUD

Medication studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What will I do during this study?

The protocol includes: Completing questionnaires.

Listed locations
ProvidenceSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 1, 2022
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Rhode Island Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT05991622
Official title
Show the full official title

Integrating Long-Acting Injectable Treatment to Improve Medication Adherence Among Persons Living With HIV and Opioid Use Disorder

Recruitment & locations

Withdrawn

Providence

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What will I need to do?

You will complete questionnaires.

Who is behind this study?

The study sponsor is Rhode Island Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Combined LAI Treatment: Cabenuva and Sublocade.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies